Beatriz Moreno Bruna-rekin lankidetzan egindako argitalpenak (6)

2024

  1. CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 2

2023

  1. Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals

    ACS Nano, Vol. 17, Núm. 23, pp. 23331-23346

  2. Modulating T Cell Responses by Targeting CD3

    Cancers, Vol. 15, Núm. 4

2022

  1. A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 413-425

  2. Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System

    Biomedicines, Vol. 10, Núm. 8

2020

  1. Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

    Molecular Therapy - Nucleic Acids, Vol. 21, pp. 192-204